Rapid removal of vancomycin by continuous veno-venous hemofiltration

被引:6
|
作者
Shah, M [1 ]
Quigley, R [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75237 USA
关键词
vancomycin; acute renal failure; continuous veno-venous hemofiltration nephrotoxicity;
D O I
10.1007/s004670000317
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We describe a 14-year-old girl with staphylococcal (coagulase-negative) ventriculo-peritoneal shunt infection, who developed oliguric acute renal failure and was found to have a serum vancomycin concentration of 250 mu g/ml. Since only about 10%-50% of vancomycin is bound to protein in blood, we employed continuous veno-venous hemofiltration (CVVH) with a high ultrafiltration rate (1,800 ml/h) for increased convective clearance to remove vancomycin, which may have contributed to the acute renal failure. At the end of 38 h of CVVH, the vancomycin concentration had decreased in an exponential manner to 27 mu g/ml. Over the subsequent 3-4 days, her renal function improved and the vancomycin concentration decreased further to <5 mu g/ml. In conclusion, we believe that a high serum vancomycin concentration may be nephrotoxic and demonstrate that CVVH can be used effectively to remove vancomycin in children with acute renal failure.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 50 条
  • [41] Risk factors for failure of continuous veno-venous hemodialysis in the treatment of acute renal failure following cardiac surgery
    Ji, Qiang
    Mei, YunQing
    Wang, XiSheng
    Feng, Jing
    Cai, JianZhi
    Sun, YiFeng
    Dewei, Wusha
    PERFUSION-UK, 2010, 25 (05): : 337 - 342
  • [42] Is cytokine removal by continuous hemofiltration feasible?
    Sieberth, HG
    Kierdorf, HP
    KIDNEY INTERNATIONAL, 1999, 56 : S79 - S83
  • [43] Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
    Joy, MS
    Matzke, GR
    Frye, RF
    Palevsky, PM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (06) : 1019 - 1027
  • [44] TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment
    Quinto, Beata Marie R.
    Iizuka, Ilson J.
    Monte, Julio C. M.
    Santos, Bento F.
    Pereira, Virgilio
    Durao, Marcelino S.
    Dalboni, Maria A.
    Cendoroglo, Miguel
    Santos, Oscar F. P.
    Batista, Marcelo C.
    CYTOKINE, 2015, 71 (02) : 255 - 260
  • [45] Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
    RH Passos
    MB Ferri
    N Akamine
    MC Batista
    JCM Monte
    BFC Santos
    VG Pereira
    MS Durao
    OFP Santos
    Critical Care, 10 (Suppl 1):
  • [46] Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia
    Agha-Razii, M
    Amyot, SL
    Pichette, V
    Cardinal, J
    Ouimet, D
    Leblanc, M
    CLINICAL NEPHROLOGY, 2000, 54 (01) : 59 - 63
  • [47] Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution
    Zimmerman, D
    Cotman, P
    Ting, R
    Karanicolas, S
    Tobe, SW
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) : 2387 - 2391
  • [48] Myoglobin clearance and removal during continuous venovenous hemofiltration
    Amyot, SL
    Leblanc, M
    Thibeault, Y
    Geadah, D
    Cardinal, J
    INTENSIVE CARE MEDICINE, 1999, 25 (10) : 1169 - 1172
  • [49] Myoglobin clearance and removal during continuous venovenous hemofiltration
    S. -L. Amyot
    M. Leblanc
    Y. Thibeault
    D. Geadah
    J. Cardinal
    Intensive Care Medicine, 1999, 25 : 1169 - 1172
  • [50] Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
    Peng, Lengyue
    Gao, Yawen
    Zhang, Guangli
    Tian, Xiaoyin
    Xu, Huiting
    Yu, Qinghong
    Cheng, Jie
    Li, Yuanyuan
    Li, Qinyuan
    Chen, Yingfu
    Zhao, Wei
    Luo, Zhengxiu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)